DK3085363T3 - Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade - Google Patents
Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade Download PDFInfo
- Publication number
- DK3085363T3 DK3085363T3 DK16154811.0T DK16154811T DK3085363T3 DK 3085363 T3 DK3085363 T3 DK 3085363T3 DK 16154811 T DK16154811 T DK 16154811T DK 3085363 T3 DK3085363 T3 DK 3085363T3
- Authority
- DK
- Denmark
- Prior art keywords
- bupivacaine
- local anesthesia
- drug
- collagen
- analgesia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (14)
1. Lægemiddelindgivelsesindretning egnet til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade på et sted i et menneske eller dyr med behov derfor, idet indretningen omfatter en fibrillær kollagenmatrix; og mindst et lægemiddel, idet det mindst ene lægemiddel er i alt væsentligt homogent dispergeret i kollagenmatricen, hvor lægemiddelindgivelsesindretningen omfatter en eller flere frysetørrede kollagensvampe, som indeholder i alt 250 mg eller 200 mg af vandfri bupivacain-hydroklorid.
2. Lægemiddelindgivelsesindretning ifølge krav 1, hvor, når mennesket eller dyret har behov for lokalanalgesi, lokalanæstesi eller nerveblokade efter gastrointestinal (GI) kirurgi, da omfatter lægemiddelindgivelsesindretningen en flerhed af svampe, som indeholder i alt 200 mg bupivacain-hydroklorid, hvor svampene har et overfladeareal på 100 cm2 og en dybde eller tykkelse på 0,5 cm.
3. Indretning ifølge kravene 1-2, hvor analgesi tilvejebringes uden bivirkninger associeret med toksicitet fra lægemiddelindgivelsesindretningen.
4. Indretning ifølge kravene 1-3, hvor indretningen reducerer patientens behovfor systemisk analgesi.
5. Anvendelse afen lægemiddelindgivelsesindretning omfattende en fibrillær kollagenmatrix; og mindst et lægemiddel, idet det mindst ene lægemiddel er i alt væsentligt homogent dispergeret i kollagenmatrixen til fremstillingen af et medikament til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i mennesket eller dyret med behov derfor, idet analgesien, anæstesien eller nerveblokaden omfatter at indgive medikamentet på stedet i et menneske eller dyr med behov derfor, hvor lægemiddelindgivelsesindretningen omfatter en eller flere frysetørrede kollagensvampe, som indeholder i alt 250 mg eller 200 mg af vandfri bupivacain-hydroklorid.
6. Anvendelse ifølge krav 5, hvor mindst en svamp placeres tilstødende det kirurgiske sted, mindst en svamp placeres på tværs af indsnittet i væggen af kropshulrummet og mindst en svamp placeres mellem hinden og huden rundt om indsnittet.
7. Anvendelse ifølge krav 6, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter en laparotomi.
8. Anvendelse ifølge kravene 6-7, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter ortopædisk, abdominal, gynækologisk eller torakale kirurgiske procedurer.
9. Anvendelse ifølge krav 8, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter godartet abdominale eller torakale kirurgiske procedurer.
10. Anvendelse ifølge krav 9, hvor anvendelsen er til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade i et menneske efter abdominale hysterektomier, myomektomi og adneks kirurgi.
11. Indretning ifølge kravene 1-4 eller anvendelsen ifølge kravene 5-10, hvor svampene har en dybde på 0,5 cm.
12. Indretning ifølge kravene 1-4 eller anvendelsen ifølge kravene 5-10, hvor hver svamp har en længde på 5 cm og bredde på 5 cm.
13. Anvendelse ifølge kravene 5-10, hvor analgesi tilvejebringes uden bivirkninger associeret med toksicitet fra lægemiddelindgivelsesindretningen.
14. Anvendelse ifølge kravene 5-10, hvor indretningen reducerer patientens behov for systemisk analgesi.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE2007/0220A IE85880B1 (en) | 2007-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
US11/692,337 US20080241243A1 (en) | 2007-03-28 | 2007-03-28 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
EP08719893.3A EP2139457B1 (en) | 2007-03-28 | 2008-03-28 | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3085363T3 true DK3085363T3 (da) | 2019-04-29 |
Family
ID=39540798
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16154811.0T DK3085363T3 (da) | 2007-03-28 | 2008-03-28 | Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade |
DK08719893.3T DK2139457T3 (da) | 2007-03-28 | 2008-03-28 | Lægemiddelafgivelsesindretning til at tilvejebringe lokal analgesi, lokal anæstesi eller nerveblokade |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08719893.3T DK2139457T3 (da) | 2007-03-28 | 2008-03-28 | Lægemiddelafgivelsesindretning til at tilvejebringe lokal analgesi, lokal anæstesi eller nerveblokade |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP3085363B1 (da) |
JP (1) | JP5372905B2 (da) |
CY (2) | CY1117814T1 (da) |
DE (1) | DE202008018583U1 (da) |
DK (2) | DK3085363T3 (da) |
ES (2) | ES2718542T3 (da) |
HR (2) | HRP20160743T1 (da) |
HU (2) | HUE043185T2 (da) |
IE (1) | IES20080229A2 (da) |
LT (1) | LT3085363T (da) |
PL (2) | PL2139457T3 (da) |
PT (2) | PT2139457T (da) |
SI (2) | SI2139457T1 (da) |
TR (1) | TR201905174T4 (da) |
WO (1) | WO2008117268A2 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE47826E1 (en) | 2007-03-28 | 2020-01-28 | Innocoll Pharmaceuticals Limited | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage |
EP2352531A2 (en) * | 2008-11-06 | 2011-08-10 | Innocoll Technologies Limited | Drug delivery implants and processes for their preparation |
US8858983B2 (en) | 2009-04-30 | 2014-10-14 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
US8911427B2 (en) | 2010-12-28 | 2014-12-16 | Medtronic, Inc. | Therapeutic agent reservoir delivery system |
EP3613413A1 (en) * | 2011-12-05 | 2020-02-26 | Incept, LLC | Medical organogel processes and compositions |
PL2802624T3 (pl) | 2012-01-09 | 2018-02-28 | Innocoll Pharmaceuticals Limited | Zmodyfikowany kolagen |
US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
JP6363115B2 (ja) * | 2013-02-28 | 2018-07-25 | ミラ ファーマ コーポレイション | 注射可能局所麻酔半固体製剤およびその組成物 |
RU2561301C1 (ru) * | 2014-10-06 | 2015-08-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный аграрный университет имени П.А. Столыпина" | Способ трансфеморальной блокады нервов мочевого пузыря у мелких животных |
US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
AU2022213016A1 (en) * | 2021-02-01 | 2023-08-24 | Massey University | Post-operative pain management |
WO2022219179A1 (en) * | 2021-04-15 | 2022-10-20 | Innocoll Pharmaceuticals Limited | Drug-release implant for soft tissue surgery |
WO2023006922A2 (en) * | 2021-07-28 | 2023-02-02 | Innocoll Pharmaceuticals Limited | Bupivacaine-collagen drug delivery implant and methods of making and using thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4125400C2 (de) * | 1991-07-31 | 2000-08-17 | Edwin Klaus | Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen |
JPH08143449A (ja) * | 1994-11-17 | 1996-06-04 | Lederle Japan Ltd | 徐放性局所麻酔用注射剤 |
US7119062B1 (en) * | 2001-02-23 | 2006-10-10 | Neucoll, Inc. | Methods and compositions for improved articular surgery using collagen |
US20080124400A1 (en) * | 2004-06-24 | 2008-05-29 | Angiotech International Ag | Microparticles With High Loadings Of A Bioactive Agent |
LT2767292T (lt) * | 2004-09-17 | 2016-12-12 | Durect Corporation | Palaikomosios vietinės anestezijos mišinys su saib |
UA88321C2 (ru) * | 2004-09-30 | 2009-10-12 | Ковалон Текнолоджиз Инк. | Неадгезивные эластичные желатиновые матрицы |
-
2008
- 2008-03-28 DK DK16154811.0T patent/DK3085363T3/da active
- 2008-03-28 PL PL08719893.3T patent/PL2139457T3/pl unknown
- 2008-03-28 TR TR2019/05174T patent/TR201905174T4/tr unknown
- 2008-03-28 DE DE202008018583.1U patent/DE202008018583U1/de not_active Expired - Lifetime
- 2008-03-28 PT PT87198933T patent/PT2139457T/pt unknown
- 2008-03-28 DK DK08719893.3T patent/DK2139457T3/da active
- 2008-03-28 EP EP16154811.0A patent/EP3085363B1/en active Active
- 2008-03-28 PL PL16154811T patent/PL3085363T3/pl unknown
- 2008-03-28 SI SI200831641A patent/SI2139457T1/sl unknown
- 2008-03-28 JP JP2010500426A patent/JP5372905B2/ja active Active
- 2008-03-28 SI SI200832058T patent/SI3085363T1/sl unknown
- 2008-03-28 IE IE20080229A patent/IES20080229A2/en not_active IP Right Cessation
- 2008-03-28 HU HUE16154811A patent/HUE043185T2/hu unknown
- 2008-03-28 EP EP08719893.3A patent/EP2139457B1/en active Active
- 2008-03-28 LT LTEP16154811.0T patent/LT3085363T/lt unknown
- 2008-03-28 WO PCT/IE2008/000035 patent/WO2008117268A2/en active Application Filing
- 2008-03-28 ES ES16154811T patent/ES2718542T3/es active Active
- 2008-03-28 HU HUE08719893A patent/HUE027803T2/en unknown
- 2008-03-28 ES ES08719893.3T patent/ES2582368T3/es active Active
- 2008-03-28 PT PT16154811T patent/PT3085363T/pt unknown
-
2016
- 2016-06-27 HR HRP20160743TT patent/HRP20160743T1/hr unknown
- 2016-07-14 CY CY20161100677T patent/CY1117814T1/el unknown
-
2019
- 2019-04-12 CY CY20191100409T patent/CY1121568T1/el unknown
- 2019-04-15 HR HRP20190699TT patent/HRP20190699T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
PL3085363T3 (pl) | 2019-08-30 |
PT2139457T (pt) | 2016-07-26 |
PL2139457T3 (pl) | 2016-11-30 |
EP2139457B1 (en) | 2016-05-04 |
CY1121568T1 (el) | 2020-05-29 |
IES20080229A2 (en) | 2008-12-24 |
WO2008117268A3 (en) | 2009-03-26 |
HUE043185T2 (hu) | 2019-08-28 |
HRP20160743T1 (hr) | 2016-09-23 |
WO2008117268A2 (en) | 2008-10-02 |
JP2010522738A (ja) | 2010-07-08 |
HRP20190699T1 (hr) | 2019-07-12 |
SI2139457T1 (sl) | 2016-09-30 |
SI3085363T1 (sl) | 2019-07-31 |
LT3085363T (lt) | 2019-06-25 |
EP2139457A2 (en) | 2010-01-06 |
DE202008018583U1 (de) | 2016-03-14 |
CY1117814T1 (el) | 2017-05-17 |
ES2582368T3 (es) | 2016-09-12 |
ES2718542T3 (es) | 2019-07-02 |
HUE027803T2 (en) | 2016-10-28 |
PT3085363T (pt) | 2019-05-16 |
TR201905174T4 (tr) | 2019-05-21 |
JP5372905B2 (ja) | 2013-12-18 |
EP3085363A1 (en) | 2016-10-26 |
EP3085363B1 (en) | 2019-03-20 |
DK2139457T3 (da) | 2016-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3085363T3 (da) | Lægemiddelindgivelsesindretning til at tilvejebringe lokalanalgesi, lokalanæstesi eller nerveblokade | |
US8034368B2 (en) | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage | |
EP1809329B1 (en) | Sustained local anesthetic composition containing saib | |
JP2004521111A (ja) | 局所麻酔薬および使用法 | |
USRE47826E1 (en) | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage | |
US20080241243A1 (en) | Drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
CA2294950C (en) | Levobupivacaine and its use | |
WO2022219179A1 (en) | Drug-release implant for soft tissue surgery | |
IE20080229U1 (en) | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
IES85185Y1 (en) | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
IE85880B1 (en) | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
IE20070220A1 (en) | A drug delivery device for providing local analgesia, local anesthesia or nerve blockade | |
CN111629713B (zh) | 用于治疗手术后疼痛的药物组合物 | |
EP2026814A2 (en) | Mirtazapine for the treatment of neuropathic pain | |
WO2021232157A1 (en) | Sustained release pharmaceutical composition | |
EA044480B1 (ru) | Фармацевтическая композиция для лечения послеоперационной боли и способ приготовления такой композиции |